Determination of CA 19-9 and CA 15-3 on Elecsys® 2010 immunoanalyzers -: Results of a field study.

被引：0
|
作者：
Domke, I
Stieber, P
van Helden, J
Friese, S
van Kamp, GJ
Roth, HJ
Troalen, F
Weisbrich, C
Wollenberg, P
机构：
[1] Roche Diagnost GmbH, Mannheim, Germany
[2] Univ Munich, Klinikum Grosshadern, Inst Klin Chem, D-8000 Munich, Germany
[3] Labor Dr Stein, Moenchengladbach, Germany
[4] MEDTRAC Laborbetriebsgesesll mbH, Poing, Germany
[5] Acad Hosp VU, Amsterdam, Netherlands
[6] Labor Dr Limbach & Kollegen, Heidelberg, Germany
[7] Inst Gustave Roussy, Villequif, France
[8] Inst Klin Chem Pathobiochem, Leipzig, Germany
[9] Labor Dr Kramer, Geesthacht, Germany
来源：
CLINICAL CHEMISTRY | 1999年 / 45卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A109 / A109
页数：1
相关论文
共 50 条
  • [31] TUMOR-MARKERS IN PATIENTS WITH CHRONIC RENAL-FAILURE TREATED BY HEMODIALYSIS - A COMPARISON OF THE ANTIGENS MCA, CA 15-3, CA 125, CA 19-9, AND CEA
    AMMON, A
    EIFFERT, H
    WEBER, MH
    RUMMEL, J
    NIEMANN, J
    ONKOLOGIE, 1988, 11 (06): : 260 - 262
  • [32] Comparison of four methods for CA 19-9 determination
    Teresa, Sandri Maria
    Passerini, R.
    Bellati, P.
    Chieregatti, I
    Dolci, A.
    TUMOR BIOLOGY, 2006, 27 : 89 - 89
  • [33] The clinical utility of ARCHITECTXR, Immuno-1, and Elecsys assays for CA 19-9
    Stenman, Ulf-Hakan
    Hotakainen, Kristina
    Tanner, Pirjo
    Alfthan, Henrik
    Haglund, Caj
    TUMOR BIOLOGY, 2007, 28 : 117 - 117
  • [34] The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology
    Sari, R
    Yildirim, B
    Sevinc, A
    Bahceci, F
    Hilmioglu, F
    HEPATO-GASTROENTEROLOGY, 2001, 48 (42) : 1616 - 1621
  • [35] Diagnostic value of Cyfra 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assay in pleural effusions: Analysis of 116 cases and review of the literature
    Shitrit, D
    Kramer, M
    Zingerman, B
    Shlomi, D
    Bargil-Shitrit, A
    LUNG CANCER, 2005, 49 : S162 - S162
  • [36] Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: Analysis of 116 cases and review of the literature
    Shitrit, D
    Zingerman, B
    Shitrit, ABG
    Shlomi, D
    Kramer, MR
    ONCOLOGIST, 2005, 10 (07): : 501 - 507
  • [37] Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® System
    Christenson, Robert H.
    Cervelli, Denise R.
    Sterner, Jamie
    Bachmann, Lauren M.
    Rebuck, Heather
    Gray, Jeffery
    Kelley, Walter E.
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : 1128 - 1136
  • [38] Establishment of ELISA on 384-well microplate for AFP, CEA, CA 19-9, CA 15-3, CA 125, and PSA-ACT: Higher sensitivity and lower reagent cost
    Wu, TL
    Sun, YC
    Chang, PY
    Tsao, KC
    Sun, CF
    Wu, JT
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2003, 17 (06) : 241 - 246
  • [39] TUMOR-MARKERS CA 19-9, CA 125, CA 72-4 AND CA 50 IN PATHOLOGY OF NEOPLASIA - RESULTS OF A 3-YEAR STUDY
    FRATTA, M
    CIOFFI, M
    DELUCIA, D
    BRESCIANI, F
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1990, 34 (04): : 285 - 288
  • [40] The Significance of Serum Tumor Markers CEA, Ca 19-9, Ca 125, Ca 15-3, and AFP in Patients Scheduled for Orthotopic Liver Transplantation: Do Elevated Levels Really Mean Malignancy?
    Baskiran, Deniz Yavuz
    Sarigoz, Talha
    Baskiran, Adil
    Yilmaz, Sezai
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (02) : 442 - 446
12345